Marko Jorg
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Real-time transcriptomic profiling in distinct experimental conditions.
Journal: eLife
Published: May 05, 2026
Novel polymer series for pharmaceutical applications: alpha-hydroxycarboxylic acid modified polymethacrylates.
Journal: International journal of pharmaceutics
Published: October 27, 2025
Sex-specific regulation of angiogenin in Alzheimer's disease.
Journal: Molecular psychiatry
Published: September 12, 2025
Complementary DNA oligonucleotide direct in-gel quantification (cDINGQ) for precise tRNA fragment analysis.
Journal: RNA (New York, N.Y.)
Published: September 02, 2025
Complementary DNA oligonucleotide direct in-gel quantification (cDINGQ) for precise tRNA fragment analysis.
Journal: RNA (New York, N.Y.)
Published: September 02, 2025
ModiDeC: a multi-RNA modification classifier for direct nanopore sequencing.
Journal: Nucleic acids research
Published: February 19, 2025
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease.
N1-methylation of adenosine (m1A) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease.
Journal: Molecular psychiatry
Published: August 18, 2023
RNA marker modifications reveal the necessity for rigorous preparation protocols to avoid artifacts in epitranscriptomic analysis.
Journal: Nucleic acids research
Published: July 20, 2021
Mitochondrial Dysfunction as a Causative Factor in Alzheimer's Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain.
Journal: Current Alzheimer research
Published: April 19, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026